Functional genomics approaches for understanding the role of noncoding RNAS in human diseases

Abstract

Noncoding RNA (NCRNA), once considered genomic "dark matter," has emerged as an essential regulator of gene expression and is rapidly implicated in the pathogenesis of various human diseases. Functional genomics has brought a revolution to our understanding of these RNA molecules, including microRNAs, long noncoding RNAs and circular RNAs (circRNAs), by enabling their expression, interaction and large-scale analysis of the regulatory network. With the advancement of high-throughput sequencing, CRISPR-based gene editing and transcription, functional genomics offers a wealth of insights into how ncRNAs contribute to the onset, progression and tissue specificity of diseases. These approaches facilitate the identification of NCRNA biomarkers, highlight their epigenetic and transcriptional control mechanisms and illustrate their interactions with DNA, RNA and proteins. In cancer, heart, neurodegenerative and autoimmune diseases, converted NCRNA profiles are now recognized as a significant reorganization of signaling pathways and cellular homeostasis. Additionally, a functional genomics background improves transcriptional noise, enhancing AIDS, clinical accuracy and medical goal discovery in separating disease-specific NCRNAs. The integration of computational biology, machine learning and systems biology further enhances our ability to interpret NCRNA tasks and predict their roles in the disease network. Despite significant progress, challenges remain in functionally validating NCRNAs and translating genomic data into clinical applications. This study discusses the latest functional genomics strategies used to examine NCRNAS and highlights their transformative ability in accurate therapy.